Skip to main content
Fig. 5 | Cardiovascular Diabetology

Fig. 5

From: A randomised, active- and placebo-controlled, three-period crossover trial to investigate short-term effects of the dipeptidyl peptidase-4 inhibitor linagliptin on macro- and microvascular endothelial function in type 2 diabetes

Fig. 5

Change from baseline after 28 days between the three treatment groups in endothelial-dependent microcirculatory function using laser-Doppler—peak blood flow (efficacy set). a Fasting. b 2-h postprandial. *Ratio of peak blood flow on day 28 to peak blood flow at baseline. †n = 40 at baseline. ‡n = 38 at baseline. CI confidence interval

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840